Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

CT-388

A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Roche · Phase 2 · Completed · Enrollment 469

NCT06525935

ArmPopulationDoseWeeksEstimandWeight change
Arm 1: PlaceboObesity or overweightn/r48n/rn/r
Arm 2: Enicepatide Dose Level 1 (Low)Obesity or overweightn/r48n/rn/r
Arm 3: Enicepatide Dose Level 2Obesity or overweightn/r48n/rn/r
Arm 4: Enicepatide Dose Level 3Obesity or overweightn/r48n/rn/r
Arm 5: Enicepatide Dose Level 4Obesity or overweightn/r48n/rn/r
Arm 6: Enicepatide Dose Level 5 (High)Obesity or overweightn/r48n/rn/r